Wiley Clinical and Health

@WileyHealth

Find the latest research in oncology and hematology, clinical health, and medical research and applied clinical practice. Unleash your next big discovery.

Global wiley.com Joined December 2012

467 Following 2.2K Followers 6.9K Posts

Latest posts 5

Wiley Clinical and Health @WileyHealth 2d

#Proteins called defensins quietly make clots harder to break down, platelets quicker to clump. 🥼

They are candidate biomarkers of clot risk in heart disease, #COVID19, or sepsis, and colchicine may block their release.

🔗Explore the latest research: bit.ly/4ilbRau

Image of a magazine cover titled "Rheumatology & Autoimmunity" from Wiley. The cover features an illustration of a hand and blood clots along with text in English and Chinese. Accompanying text reads: "Explore how immune proteins called defensins contribute to blood clots" with a "Read Now" prompt.

Wiley Clinical and Health @WileyHealth 2d

Join guests Kelly Walker and Jane Houston as they discuss their neurodivergence research and midwifery education.

Tune in to this candid conversation about putting students first to build our midwifery workforce for the long term.

🎧 Listen now: bit.ly/4Ae3dAF

Wiley Clinical and Health @WileyHealth 3d

Not sure where to submit? Paste your title and abstract into our Journal Finder, and our AI-powered abstract matching recommends relevant journals from 1,800+ titles. Try it today:
bit.ly/4BGWEYN
#ThursdayPublishingTips

A person typing on a laptop. The image includes text: "Wiley" and "#ThursdayPublishingTips Match Your Abstract to a Journal" with a "Learn More" button.

Wiley Clinical and Health @WileyHealth 3d

In a world of inequality, vaccines are more important than ever.

From the challenges posed by antivaxxers to the development of new vaccines, this Special Issue raises awareness of vaccination-related dilemmas to promote child health.

Read now -> bit.ly/4efQftD

0:05

Wiley Clinical and Health @WileyHealth 4d

A study published in @AjHematology reveals that bevacizumab is safe and effective systemic treatment for severe bleeding from acquired gastrointestinal vascular malformations.

@ASHClinicalNews summarizes the findings: bit.ly/4ik2VlA

🔗 to study: bit.ly/4iTyN0v

A study published in the American Journal of Hematology reveals that bevacizumab is safe and effective systemic treatment for severe bleeding from acquired gastrointestinal vascular malformations.